Cooper Companies (The) (COO)
NASDAQ: COO · Health Care Supplies · San Ramon, CA
Our rating: Neutral
Neutral reaffirmed at $54.61, moderate conviction, September 16, 2026.
Breaks if: The Neutral call turns Cautious if revenue growth decelerates below 3% on a trailing-twelve-month basis within the next four quarters, or if the net margin compresses below 7.5% without a corresponding lift in free cash flow — signaling that the amortization burden is worsening rather than simply persisting. It turns Positive if revenue growth reaccelerates above 8% year-on-year for two consecutive quarters, or if the stock pulls back enough that the FCF yield rises above 5.5% — implying a price at or below roughly $44 on current earnings.
Key figures
| Market value | $11.2B |
|---|---|
| Revenue, last 12 months | $4.2B |
| Net income, last 12 months | $570M |
| Free cash flow, last 12 months | $678M |
| Price to earnings | 19.6× |
| Free cash flow yield | 6.1% |
| Dividend yield | 0.0% |
| Operating margin | 12.8% |
| Return on equity | 6.8% |
| Beta to the S&P 500 | 0.63 |
| Volatility, annualized | 32.5% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| July 31, 2026 | $1.1B | 0.6% | $2.24 | $273M |
| April 30, 2026 | $1.1B | 7.9% | $-0.40 | $96M |
| January 31, 2026 | $1.0B | 6.2% | $0.66 | $159M |
| October 31, 2025 | $1.1B | 4.6% | $0.42 | $150M |
| July 31, 2025 | $1.1B | 5.7% | $0.49 | $165M |
| April 30, 2025 | $1.0B | 6.3% | $0.44 | $18M |
| January 31, 2025 | $965M | 3.6% | $0.52 | $101M |
| October 31, 2024 | $1.0B | 9.8% | $0.59 | $128M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.12B: Claude 32%, Gemini 40%, Mistral 30%
- Diluted earnings per share are at least $0.42: Claude 58%, Gemini 70%, Mistral 60%
- Free cash flow for the quarter is at least $0.15B: Claude 62%, Gemini 55%, Mistral 55%
9 ledger entries and 59 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.